MDB Capital Holdings, LLC (NASDAQ:MDBH) Short Interest Down 38.0% in February

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the recipient of a significant decline in short interest during the month of February. As of February 27th, there was short interest totaling 1,099 shares, a decline of 38.0% from the February 12th total of 1,772 shares. Based on an average daily volume of 3,828 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.0% of the company’s shares are short sold. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 3,828 shares, the days-to-cover ratio is currently 0.3 days.

MDB Capital Stock Down 4.5%

Shares of NASDAQ:MDBH traded down $0.13 during midday trading on Friday, hitting $2.69. 2,912 shares of the stock traded hands, compared to its average volume of 6,126. The business’s 50 day moving average is $3.26 and its two-hundred day moving average is $3.45. The stock has a market capitalization of $27.31 million, a PE ratio of 3.03 and a beta of 1.05. MDB Capital has a one year low of $2.80 and a one year high of $6.60.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of MDBH. Citadel Advisors LLC bought a new stake in shares of MDB Capital in the 3rd quarter worth approximately $43,000. DRW Securities LLC purchased a new position in shares of MDB Capital during the fourth quarter valued at approximately $40,000. Finally, Raymond James Financial Inc. bought a new position in shares of MDB Capital during the second quarter valued at approximately $27,000. Institutional investors own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d)” rating on shares of MDB Capital in a report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

MDB Capital Company Profile

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.